UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000014668
Receipt No. R000017061
Official scientific title of the study A Randomized Controlled Trial compares the efficacy of Moviprep vs Muben on the bowel preparation of the patients who undergo colorectal endoscopic submucosal dissection
Date of disclosure of the study information 2014/08/15
Last modified on 2017/01/28 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A Randomized Controlled Trial compares the efficacy of Moviprep vs Muben on the bowel preparation of the patients who undergo colorectal endoscopic submucosal dissection
Title of the study (Brief title) MOVI STUDY
Region
Japan

Condition
Condition Colorectal tumor
Classification by specialty
Gastroenterology Nursing
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To compare the effect of Moviprep (low-volume colonoscopy prep) and Muben (standard-volume) on the bowel preparation for the patients undergo colorectal endoscopic submucosal dissection.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Phase II

Assessment
Primary outcomes Preparation time
Key secondary outcomes Boston Bowel Preparation Scale score, acceptability, taste, frequencies of stool, total volume of the prep, complication rate.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification YES
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 Moviprep 1.5L ~ 2L
Interventions/Control_2 Muben 3L ~ 4L
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >=
Gender Male and Female
Key inclusion criteria Patients who underwent colorectal endoscopic submucosal dissection (ESD) at National Cancer Center Hospital.
1. Indication for colorectal ESD
2. Irrespective of number of the lesion
3. Age from 20 years old to 75 years old
4. Performance status 0, 1, 2
5. Patients who has written informed consent for this study
Key exclusion criteria 1. Patients having risk of perforation, obstruction and suspicious of ileum.
2. Toxic megacolon
3. Allergy for Moviprep and Muben
4. Dehydration
5. Mental disease
6. Without written informed consent
7. Angina pectoris and/or past history of myocardial infarction within 6 months.
8. Active inflammatory bowel diseases
9. Past history of convulsive attack
10. Serum creatinine level &#8805;1.3 mg/dL
11. Others (depends on the chief physician)
Target sample size 100

Research contact person
Name of lead principal investigator Takahisa Matsuda
Organization National Cancer Center Hospital
Division name Endoscopy Division
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo
TEL +81-3-3542-2511
Email tamatsud@ncc.go.jp

Public contact
Name of contact person Masayoshi Yamada
Organization National Cancer Center Hospital
Division name Endoscopy Division
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo
TEL +81-3-3542-2511
Homepage URL
Email masyamad@ncc.go.jp

Sponsor
Institute National Cancer Center Hospital
Institute
Department

Funding Source
Organization Ajinomoto Pharmaceuticals Co., LTD
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 国立がん研究センター中央病院

Other administrative information
Date of disclosure of the study information
2014 Year 08 Month 15 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2013 Year 07 Month 20 Day
Anticipated trial start date
2014 Year 08 Month 15 Day
Last follow-up date
2015 Year 08 Month 15 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 07 Month 28 Day
Last modified on
2017 Year 01 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017061